August 19, 2020 07:05 AM EDTUpdated 10:41 AM

Covid-19 roundup: Fauci, Collins intervene to stop FDA plasma authorization, citing weak data; Roche, Regeneron try to take antibodies global

Amber Tong

Senior Editor

Max Gelman

Senior Editor

The FDA has placed on hold an emergency authorization for the use of plasma as a Covid-19 treatment following the intervention of top federal health …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Fauci, Collins intervene to stop FDA plasma authorization, citing weak data; Roche, Regeneron try to take antibodies global

Amber Tong

Senior Editor

Max Gelman

Senior Editor

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Covid-19 roundup: Fau­ci, Collins in­ter­vene to stop FDA plas­ma au­tho­riza­tion, cit­ing weak da­ta; Roche, Re­gen­eron try to take an­ti­bod­ies glob­al

Senior Editor

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Fauci, Collins intervene to stop FDA plasma authorization, citing weak data; Roche, Regeneron try to take antibodies global